PTAB & ITC

Applying our savvy litigation skills and technical expertise to challenge patents in fast-paced, alternative venues to district court litigation

Relying on our deep bench of seasoned litigators, RMMS regularly advises clients on Patent Trials and Appeal Board (PTAB) strategies, particularly when there is risk of parallel district court litigation.

We develop and implement comprehensive and strategic PTAB patent challenges that considers discretionary denial, stays, and estoppel exposure. Clients rely on our strategic approach to PTAB patent challenges to efficiently clear a path to market that often differentiates their position from others in a crowded landscape.  

Our PTAB experience includes routinely advising on and filing Inter Partes Review petitions on pharmaceutical patents related to small molecule and biologic products, including patents related to:

  • synthetic chemistry
  • intermediates and degradation products
  • polymorphism
  • pharmaceutical formulations
  • method of use / dosing patents

RMMS leverages the skills of its experienced patent litigators to win in the fast-paced, high-stakes forum of the U.S. International Trade Commission (ITC).

RMMS knows what it takes to litigate efficiency and successfully under ITC’s unique rules and procedures for resolving patent disputes.  Leveraging the technical knowledge and extensive litigation experience of our patent litigators, we have successfully protected our client’s leading market position by asserting its patent in this specialized venue.  

More and more leaders in the life sciences industry are turning to RMMS for successful IP outcomes.

Here’s what they have to say.

What's your biggest IP challenge?

The life sciences team at RMMS is ready to help.

Contact Us